Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials

Overview of attention for article published in Stem Cell Research & Therapy, April 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 5 X users
patent: 1 patent

reddit: 1 Redditor

Readers on

mendeley: 343 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 1,737 followers.

RT @kosheeka: #MSCs can now send tiny messages in #exosomes to heal injuries & fight disease! These #nanoparticles carry proteins & instru…

#MSCs can now send tiny messages in #exosomes to heal injuries & fight disease! These #nanoparticles carry proteins & instructions for repair, offering a safer & more targeted approach. Read More: https://t.co/p3GFYdjWbL #CellTherapy #Sci…

この論文、エクソソームを使用した進行中及び完了した臨床研究（～2022 / 9 ）をまとめたレビューで分かりやすい。これはさすがにエビデンスといえるのでは。もちろん、自由診療での使用の是非とは別問題だが、臨床試験における間葉系間質/幹細胞 (MSC) 由来のエクソソーム …

Daily word art by Kesho and article by Lotfy et al. at: https://t.co/QFhM5k3dwN https://t.co/AVNOaKkm0f

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.